Description of Lgd 4033
Product Name | LGD-4033 |
Alias | VK5211 |
CAS NO. | 1165910-22-4 |
Molecular Formula | C14H12F6N2O |
Molecular Weight | 338.25 |
Purity | 99% |
Appearance | White Powder |
Grade | rmaceutical Grade |
1) Product Name: lgd-4033/cas 1165910-22-4 2) Assay: 99% 3) Appearance: White powder4) Introduction: LGD-4033 rmacological profile similar to that of enobosarm, , MK-2866 MK-677, Ibutamoren, a HORMONE secretagogue A HORMONE secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of HORMONE with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an route of administration.How LGD-4033 Works?LGD-4033 works by tying androgen receptors selectively. It shows activity in the bones and muscles instead of harmfully affecting the prostate and sebaceous glands which usually happens when using steroids. LGD-4033 just concluded a study called se I Multiple Ascending Dose which included fit volunteers. This was an unplanned, double bind analysis stage that included a placebo. The objective was to form that using LGD-4033 was harmless and easy to stomach with a dose not beyond 22 mg a day.LGD-4033 has the ability to set off the following benefits when taken consistently:An increase in strength levelsLean muscle mass improvedA drop in body fatHas healing propertiesDoes not cause the undesirable side effects caused by prohormones and steroidsUsage of LGD-4033 Anabolicum (LGD), like other popular SARMS, is very versatile and has a list of benefits no matter the goal of the user. Whether it's lean muscle mass, maintenance of your hard earned gains during a cutting cycle, or bridging the gap between cycles, LGD-4033 can be a very beneficial tool. Studies suggest that this SARM will lend therapeutic benefit to many HORMONE deficiency conditions. In fact, it's not unheard of to hear of improvements in joint pain or nagging injuries after starting a course of Anabolicum (LGD), much like its cousin (MK-2866). In addition, LGD can increase strength, vascularity, and fat loss while bulking, and it can help during "recomposition" (recomp).Related Sarms:
,MK-2866, Enobosarm | 841205-47-81202044-20-9 | Enobosarm (, MK-2866, GTx-024) |
Andarine (S-4) | 401900-40-1 | partial agonist, intended mainly for treatment of benign prostatic hypertro |
MK-677, Ibutamoren, | 159752-10-0 | a HORMONE secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | rmacological profile similar to that of enobosarm, |
GW-501516 | 317318-70-0 | It had been investigated as a potential treatment for obesity,diabetes,dyslipidemia and cardiovascular disease |
AICAR | 2627-69-2 | AICAR acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
SR9009 | 137986-29-9 | Research chemical |
SR9011 | 1379686-30-2 | Research chemical |
RAD-140 | 118237-47-0 | Research chemical |
Flibanserin | 167933-07-5 | developmental code name BIMT-17; that is being studied as a non-hormonal treatment for pre-menopausal women with HSDD. |
77472-70-9 | nylpiracetam (notropil | |
Coluracetam | 135463-81-9 | code name BCI-540; formerly MKC-231 |
Sunifiram | 314728-85-3 | DM-235 |
Pirfenidone | 53179-13-8 | Pirespa, INN, BAN |